NCI, NHLBI/PBMTC First International Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges-thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive Risks

Overview

Journal Biol Blood Marrow Transplant

Date 2011 Oct 19

PMID 22005649

Citations 33

Authors

Christopher C Dvorak

Clarisa R Gracia

Jean E Sanders

Edward Y Cheng

K Scott Baker

Michael A Pulsipher

Anna Petryk

Affiliations

Soon will be listed here.

Abstract

The endocrine system is highly susceptible to damage by high-dose chemotherapy and/or irradiation before hematopoietic cell transplantation (HCT) during childhood. The specific endocrine organs most affected by HCT include the thyroid gland, the pituitary, and the gonads. In addition, hormones that support development and stability of the skeletal system are also affected. Insufficiency of thyroid hormone is 1 of the most common late sequelae of HCT, and occurs more often in young children. Deficiency in the pituitary's production of growth hormone is a problem of unique concern to the pediatric population. The reproductive risks of HCT depend on the patient's gender and pubertal status at the time of HCT. Pubertal or gonadal failure frequently occurs, especially in females. Infertility risks for both genders remain high, whereas methods of fertility preservation are limited in all but postpubertal males. Bone health post-HCT can be compromised by low bone mineral density as well as avascular necrosis, but the data on both problems in the pediatric HCT population are limited. In this paper, the current state of knowledge, gaps in that knowledge, and recommendations for future research are addressed in detail for each of these systems.

Citing Articles

Late Effects Following Hematopoietic Stem Cell Transplantation Among Childhood Transplant Survivors with Fanconi Anemia.

Ozkocer C, Visal Okur F, Demirbilek H, Altintas B, Cetin N, Kuskonmaz B Turk J Haematol. 2024; 42(1):15-24.

PMID: 39513346 PMC: 11869150. DOI: 10.4274/tjh.galenos.2024.2024.0189.

Thyroid complications after hemopoietic stem cell transplantation in children and adolescents.

Fotiadou A, Paisiou A, Goussetis E, Kafetzi M, Karayanni V, Peristeri I Hormones (Athens). 2024; 23(4):699-707.

PMID: 39004683 DOI: 10.1007/s42000-024-00584-5.

Thyroid function disorders and secondary cancer following haematopoietic stem cell transplantation in pediatrics: State of the art and practical recommendations for a risk-based follow-up.

Cattoni A, Molinari S, Riva B, Di Marco S, Adavastro M, Faraguna M Front Endocrinol (Lausanne). 2023; 13:1064146.

PMID: 36619560 PMC: 9811586. DOI: 10.3389/fendo.2022.1064146.

Endocrine Sequelae in 157 Pediatric Survivors of Hematopoietic Stem Cell Transplantation (HSCT).

Guemes M, Martin-Rivada A, Bascuas Arribas M, Andres-Esteban E, Molina Angulo B, Pozo Roman J J Endocr Soc. 2022; 7(2):bvac183.

PMID: 36532360 PMC: 9753088. DOI: 10.1210/jendso/bvac183.

Gonadotropin-releasing hormone agonist for the preservation of ovarian function in survivors of haematopoietic stem cell transplantation for haematological diseases.

Wang Z, An J, Wang C BMC Womens Health. 2022; 22(1):436.

PMID: 36345026 PMC: 9641837. DOI: 10.1186/s12905-022-02039-8.

References

Bedaiwy M, El-Nashar S, Saman A, Evers J, Sandadi S, Desai N . Reproductive outcome after transplantation of ovarian tissue: a systematic review. Hum Reprod. 2008; 23(12):2709-17. DOI: 10.1093/humrep/den301. View

Savani B, Montero A, Wu C, Nlonda N, Read E, Dunbar C . Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2005; 11(3):223-30. DOI: 10.1016/j.bbmt.2004.12.328. View

Valimaki M, Kinnunen K, Volin L, Tahtela R, Loyttyniemi E, Laitinen K . A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant. 1999; 23(4):355-61. DOI: 10.1038/sj.bmt.1701586. View

Lee W, Cho S, Oh E, Oh K, Lee J, Yoon K . The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab. 2002; 87(1):329-35. DOI: 10.1210/jcem.87.1.8135. View

Quinn B, Kelly D . Sperm banking and fertility concerns: enhancing practice and the support available to men with cancer. Eur J Oncol Nurs. 2003; 4(1):55-8. DOI: 10.1054/ejon.2000.0078. View

Johnson J, Canning J, Kaneko T, Pru J, Tilly J . Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428(6979):145-50. DOI: 10.1038/nature02316. View

Savani B, Koklanaris E, Le Q, Shenoy A, Goodman S, Barrett A . Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2009; 15(3):377-81. PMC: 3768008. DOI: 10.1016/j.bbmt.2008.11.032. View

Wyns C, Curaba M, Vanabelle B, Van Langendonckt A, Donnez J . Options for fertility preservation in prepubertal boys. Hum Reprod Update. 2010; 16(3):312-28. DOI: 10.1093/humupd/dmp054. View

Atkinson K, Cohen M, Biggs J . Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. Bone Marrow Transplant. 1987; 2(4):421-6. View

10.

Demeestere I, Simon P, Buxant F, Robin V, Fernandez S, Centner J . Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006; 21(8):2010-4. DOI: 10.1093/humrep/del092. View

11.

Bailey H, Kappy M, Giller R, Gralla J . Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr Blood Cancer. 2008; 51(3):405-9. DOI: 10.1002/pbc.21634. View

12.

Fortin M, Raymond M, Madore F, Fugere J, Paquet M, St-Louis G . Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin-sirolimus combination. Am J Transplant. 2004; 4(6):946-52. DOI: 10.1111/j.1600-6143.2004.00428.x. View

13.

Hammond C, Abrams J, Syrjala K . Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol. 2007; 25(23):3511-7. PMC: 6391980. DOI: 10.1200/JCO.2007.10.8993. View

14.

Carlson K, Simonsson B, Ljunghall S . Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int. 1994; 55(6):408-11. DOI: 10.1007/BF00298552. View

15.

Schimmer A, Minden M, Keating A . Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transplant. 2000; 6(2A):175-81. DOI: 10.1016/s1083-8791(00)70040-1. View

16.

Donnez J, Dolmans M, Demylle D, Jadoul P, Pirard C, Squifflet J . Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364(9443):1405-10. DOI: 10.1016/S0140-6736(04)17222-X. View

17.

Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T . Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab. 2004; 89(12):5981-6. DOI: 10.1210/jc.2004-0836. View

18.

Lafforgue P . Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine. 2006; 73(5):500-7. DOI: 10.1016/j.jbspin.2006.01.025. View

19.

Carpenter P, Hoffmeister P, Chesnut 3rd C, Storer B, Charuhas P, Woolfrey A . Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007; 13(6):683-90. DOI: 10.1016/j.bbmt.2007.02.001. View

20.

Galotto M, Berisso G, Delfino L, Podesta M, Ottaggio L, DallOrso S . Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999; 27(9):1460-6. DOI: 10.1016/s0301-472x(99)00076-4. View